Mechanisms of autoimmunity

Immunologic Research

Volumn 27, Issue 2-3, 2003, Pages 203-217

  Eisenberg, Robert ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoantibodies; Autoimmunity; B cells; Self tolerance; SLE

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIMETABOLITE; AUTOANTIBODY; AUTOANTIGEN; FAS LIGAND; IMMUNOSUPPRESSIVE AGENT;

ANIMAL MODEL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BIOCHEMISTRY; BONE MARROW; CELL ACTIVITY; CELL FUNCTION; CHIMERA; DRUG EFFICACY; DRUG TARGETING; GENE MUTATION; GENETIC MODEL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SELF TOLERANCE;

EID: 0041519183     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:27:2-3:203     Document Type: Review

References (100)

1. Howie JB, Helyer BJ: The immunology and pathology of NZB mice. Adv Immunol 1968;9:215-266.
2. Wakeland EK, Foppoli, JM, Benedict AA: Genetic dissection of lupus nephritis in murine models of SLE. J Clin Immunol 1997;17:272-281.
3. Vyse TJ, Kotzin BL: Genetic susceptibility to systemic lupus erythematosus., in Annual Review of Immunology Paul WE, Fathman CG, Glimcher LH, (eds.) Palo Alto, Annual Reviews, Inc., 1998, pp. 261-292.
4. Boackle SA, Holers VM, Chen X, et al: Cr2, a candidate gene in the murine Slelc lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001;15:775-785.
5. Morel L, Blenman KR, Croker BP, et al: The major murine systemic lupus erythematosus susceptibility locus, Slel, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001;98:1787-1792.
6. Rozzo SJ, Allard JD, Choubey D, et al: Evidence for an Interferon-Inducible Gene, Ifi202, in the Susceptibility to Systemic Lupus. Immunity 2001;15:435-443.
7. Ibnou-Zekri N, Vyse TJ, Rozzo SJ, et al: MHC-linked control of murine SLE. Curr Top Microbiol Immunol 1999;246:275-280.
8. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991;9:243-269.
9. Eisenberg RA, Dixon FJ: Effect of castration on male-determined acceleration of autoimmune disease in BXSB mice. J Immunol 1980;125:1959-1961.
10. Eisenberg RA, Izui S, McConahey PJ, et al.: Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J Immunol 1980;125:1032-1036.
11. Chan OT, Madaio MP, Shlomchik MJ: The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999;169:107-121.
12. Shlomchik MJ, Craft JE, Mamula MJ: From T to B and back again: positive feedback in systemic autoimmune disease. Nature Rev Immunol 2001;1:147-153.
13. Gleichmann H, Gleichmann E, Andre-Schwartz J, et al.: Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med 1972;135:516-532.
14. Via CS, Sharrow SO, Shearer GM: Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol 1987;139:1840-1849.
15. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al.: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
16. Eisenberg RA, Tan EM, Dixon FJ: Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med 1978;147:582-587.
17. Elkon KB, Bonfa E, Llovet R, et al.: Association between anti-Sm and antiribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J Immunol 1989;143:1549-1554.
18. Satoh M, Langdon JJ, Chou CH, et al.: Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 1994;73:132-141.
19. Treadwell EL, Cohen P, Williams D, et al.: MRL mice produce anti-Su autoantibody, a specific marker for systemic lupus erythematosus. J Immunol 1993;150:695-699.
20. Davignon JL, Cohen PL, Eisenberg RA: Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negativeT cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice. J Immunol 1988;141:1848-1854.
21. Theofilopoulos AN, Eisenberg RA, Bourdon M, et al.: Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med 1979;149:516-534.
22. Nagata S, Golstein P: The Fas death factor. Science 1995;267:1449-1456.
23. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
24. Izui S, Kelley VE, Masuda K, et al.: Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1984;133:227-233.
25. Roths JB,Murphy ED, Eicher EM: A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984;159:1-20.
26. Theofilopoulos AN, Balderas RS, Gozes Y, et al.: Association of lpr gene with graft-vs.-host disease-like syndrome. J Exp Med 1985;162:1-18.
27. Sobel ES, Katagiri, T, Katagiri K, et al.: An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med 1991;173:1441-1449.
28. Sobel ES, Kakkanaiah VN, Schiffenbauer J, et al.: Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras. J Immunol 1998;160:1497-1503.
29. Weintraub JP, Godfrey V, Wolthusen PA, et al.: Immunological and pathological consequences of mutations in both Fas and Fas ligand. Cell Immunol 1998;186:8-17.
30. Maldonado MA, Luo HY, Eisenberg RA: LPR B cells still show an intrinsic defect essential for autoantibody production in the absence of FasL overexpression. Arthritis & Rheumatism 2001;44:S287.
31. Kakkanaiah VN, Sobel ES, MacDonald GC, et al.: B cell genotype determines the fine specificity of autoantibody in lpr mice. J Immunol 1997;159:1027-1035.
32. Katagiri T, Cohen PL, Eisenberg RA: The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J Exp Med 1988;167:741-751.
33. Sobel ES, Cohen PL, Eisenberg RA: lpr T cells are necessary for autoantibody production in lpr mice. J Immunol 1993;150:4160-4167.
34. Fossati L, Sobel ES, Iwamoto M, et al.: The Yaa gene-mediated acceleration of murine lupus: Yaa-T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo. Eur J Immunol 1995;25:3412-3417.
35. Sobel ES, Kakkanaiah VN, Cohen PL, et al.: Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. International Immunology 1993;5:1275-1278.
36. MacDonald GC, Kakkanaiah VN, Sobel ES, et al.: In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. J Immunol 1995;154:444-449.
37. Maldonado MA, MacDonald GC, Kakkanaiah VN, et al.: Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo. J Immunol 1999;163:3138-3142.
38. Katagiri T, Azuma S, Toyoda Y, et al.: Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene. J Immunol 1992;148:430-438.
39. Kakkanaiah VN, MacDonald GC, Cohen PL, et al.: Suppression and reversal of gld disease by parabiosis with normal mice. Clin Immunol Immunopathol 1996;78:6-13.
40. Reap EA, Felix NJ, Wolthusen PA, et al.: bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J Immunol 1995;155:5455-5462.
41. Herron LR, Eisenberg RA, Roper E, et al.: Selection of the T cell receptor repertoire in Lpr mice. J Immunol 1993;151:3450-3459.
42. Maldonado MA, Eisenberg RA, Roper E, et al.: Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J Exp Med 1995;181:641-648.
43. Israel EJ, Wilsker DF, Hayes KC, et al.: Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 1996;89:573-578.
44. Sobel ES, Kakkanaiah VN, Kakkanaiah M, et al.: Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand. J Immunol 1995;154:459-464.
45. Dhein J, Walczak H, Baumler C, et al.: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
46. Eisenberg RA, Craven SY, Warren RW, et al.: Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Clin Invest 1987;80:691-697.
47. Eisenberg RA, Craven SY, Fisher CL, et al.: The genetics of autoantibody production in MRL/lpr lupus mice. Clin Exp Rheumatol 1989;7:S35-S40.
48. Halpern MD, Craven SY, Cohen PL, et al.: Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus. J Immunol 1993;151:7268-7272.
49. Maldonado MA, Kakkanaiah V, MaCdonald GC, et al.: The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 1999;162:6322-6330.
50. Robinson DR, Prickett JD, Polisson R, et al.: The protective effect of dietary fish oil on murine lupus. Prostaglandins 1985;30:51-75.
51. Bernard NF, Eisenberg RA, Cohen P.L: Response of MRL/Mp-+/+ mice to mouse Sm: non-H-2-linked genes determine T cell recognition. J Immunol 1985;134:1422-1425.
52. Bernard NF, Eisenberg RA, Cohen PL: H-2-linked Ir gene control of T cell recognition of the Sm nuclear autoantigen and the aberrant response of autoimmune MRL/Mp-+/+ mice. J Immunol 1985;134:3812-3818.
53. Sobel ES, Kakkanaiah VN, Kakkanaiah M, et al.: T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol 1994;152:6011-6016.
54. Freed JH, Marrs A, VanderWall J, et al.: MHC class II-bound self peptides from autoimmune MRL/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus. J Immunol 2000;164:4697-4705.
55. Eisenberg RA, Pisetsky DS, Craven SY, et al.: Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies. J Clin Invest 1990;85:86-92.
56. Eisenberg RA, Winfield JB, Cohen PL: Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol 1982;129:2146-2149.
57. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, et al.: The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811.
58. Shlomchik M, Nemazee D, van Snick J, et al.: Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). II. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization. J Exp Med 1987;165:970-987.
59. Shlomchik MJ, Aucoin AH, Pisetsky DS, et al.: Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 1987;84:9150-9154.
60. Eisenberg RA, Theofilopoulos AN, Dixon FJ: Use of bovine conglutinin for the assay of immune complexes. J Immunol 1977;118:1428-1434.
61. Dixon FJ, Andrews BS, Eisenberg RA, et al.: Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthrit Rheum 1978;21:S64-S67.
62. Bloom DD, Davignon JL, Retter MW, et al.: V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J Immunol 1993;150:1591-1610.
63. Bloom DD, Davignon JL, Cohen PL, et al.: Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol 1993;150:1579-1590.
64. Retter MW, Cohen PL, Eisenberg RA, et al.: Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J Immunol 1996;156:1296-1306.
65. Eisenberg RA, Sobel ES, Reap EA, et al.: The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice. Sem Immunol 1994;6:49-54.
66. Reap EA, Sobel ES, Cohen PL, et al.: Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin Immunol Immunopathol 1996;78:21-29.
67. Reap EA, et al.: Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med 1993;177:69-78.
68. Bell CG: Ly-1 CD5 B1 cells in normal and in autoimmune prone-mice. Biochem Soc Trans 1993;21:288S.
69. Grillo-Lopez AJ: Rituximab: an insider's historical perspective. Semin Oncol 2000;27:9-16.
70. Treon SP, Anderson KC: The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders. Semin Oncol 2000;27:79-85.
71. Tedder TF, Klejman G, Disteche CM, et al.: Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19. J Immunol 1988;141:4388-4394.
72. O'Keefe TL, et al.: Mice carrying a CD20 gene disruption. Immunogenetics 1998;48:125-132.
73. Sherer Y, Shoenfeld Y: Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998;22:873-881.
74. Aractingi S, et al.: Microchimerism in human diseases. Immunol Today 2000;21:116-118.
75. Nelson JL: Microchimerism: implications for autoimmune disease. Lupus 1999;8:370-374.
76. van der Veen FM, Rolink AG, Gleichmann E: Autoimmune disease strongly resembling systemic lupus erythematosus (SLE) in F1 mice undergoing graft-versus-host reaction (GVHR). Adv Ex Med Biol 1982;149:669-677.
77. van Rappard-Van der Veen FM, Kiesel U, Poels L, et al: Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. J Immunol 1984;132:1814-1820.
78. van Rappard-van der Veen FM, Kong YM, Rose NR, et al.: Injection of mouse thyroglobulin and/or adult thymectomy do not brea tolerance to thyroglobulin during the lupus like graft versus host disease in mice. Clin Exp Immunol 1984;55:525-534.
79. Morris SC, Cheek RL, Cohen PL, et al.: Allotype-specific immuno-regulation of autoantibody production by host B cells in chronic graft-versus host disease. J Immunol 1990;144:916-922.
80. Reap EA, et al.: Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol 1993;151:7316-7323.
81. Morris SC, Cheek RL, Cohen PL, et al.: Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 1990;171:503-517.
82. Eisenberg RA, Cohen PL: Class II major histocompatibility antigens and the etiology of systemic lupus erythematosus. Clin Immunol Immunopathol 1983;29:1-6.
83. Laufer TM, Fan L, Glimcher LH: Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol 1999;162:5078-5084.
84. Bradley DS, Jennette JC, Cohen PL, et al.: Chronic graft versus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci. J Immunol 1994;152:1960-1969.
85. Chen F, Maldonado MA, Madaio M, et al.: The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. J Immunol 1998;161:5880-5885.
86. Feuerstein N, Chen F, Madaio M, et al.: Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol 1999;163:5287-5297.
87. Morris SC, Cohen PL, Eisenberg RA: Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin Immunol Immunopathol 1990;57:263-273.
88. Klinman DM, Eisenberg RA, Steinberg AD: Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. J Immunol 1990;144:506-511.
89. Sekiguchi DR, Jainandunsing SM, Fields ML, et al.: Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 2002;168:4142-4153.
90. Goodnow CC, Glynne R, Mack D, et al.: Glimpses into the balance between immunity and self-tolerance. Ciba Found Symp 1997;204:190-202.
91. Cornall RJ, Goodnow CC: B cell antigen receptor signalling in the balance of tolerance and immunity. Novartis Found Symp 1998;215:21-30.
92. Goodnow CC, Glynne R, Mack D, et al.: Mechanisms of self-tolerance and autoimmunity: from whole-animal phenotypes to molecular pathways. Cold Spring Harb Symp Quant Biol 1999;64:313-322.
93. Prak EL, Weigert M: Light chain replacement: a new model for antibody gene rearrangement. J Exp Med 1995;182:541-548.
94. Chen C, Nagy Z, Radic MZ, et al.: The site and stage of anti-DNA B-cell deletion. Nature 1995;373:252-255.
95. Chen C, Prak EL, Weigert M: Editing disease-associated auto-antibodies. Immunity 1997;6:97-105.
96. Ibrahim SM, Weigert M, Basu C, et al.: Light chain contribution to specificity in anti-DNA antibodies. J Immunol 1995;155:3223-3233.
97. Mandik-Nayak L, Bui A, Noorchashm H, et al.: Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med 1997;186:1257-1267.
98. Noorchashm H, Bui A, Li HL, et al.: Characterization of anergic anti-DNA B cells: B cell anergy is a T cell- independent and potentially reversible process. Int Immunol 1999;11:765-776.
99. Hegde P, Qi R, Abernathy K, et al.: A concise guide to cDNA microarray analysis. Biotechniques 2000;29:548-556.
100. Fahrer AM, Bazan JF, Papathanasiou P, et al.: A genomic view of immunology. Nature 2001;409:836-838.